Dec 22, 2022 · In this study, we evaluated the effects of fluoroquinolones (moxifloxacin and ciprofloxacin) and aminoglycosides (tobramycin and gentamycin) on T3SS expression and toxicity, in …

Nov 30, 2023 · The primary aim of this study was to comprehensively evaluate and compare resistance patterns among widely used antibiotic classes, namely carbapenems, fluoroquinolones, and …

As of 2023, Pseudomonas aeruginosa breakpoints were revised, and tobramycin is now the only recommended aminoglycoside for systemic therapy. Amikacin is effective against P. aeruginosa only …

Nov 6, 2022 · Aminoglycosides and fluoroquinolones are among the most used antibiotics in synergy with beta-lactams. The objective of this work was to detect genes associated with resistance to …

This year’s update, the M100-Ed33, was published in February, and will significantly affect clinical practices. Objective: To highlight and explain the rationale of the changes and their clinical...

Aug 7, 2024 · This guidance document provides recommendations to clinicians for treatment of infections caused by extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), …

Dec 11, 2024 · Noteworthy combinations include fluoroquinolones with fosfomycin and aminoglycosides for enhanced activity against Gram-negative organisms and fluoroquinolones with minocycline and …